CLINICAL_TRIALS ClinicalTrials.gov record update

CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02109250
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:35.278271+00:00
Published At: 2017-05-02T00:00:00+00:00
Record Updated At: 2017-05-02
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Metastatic Medullary Thyroid Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-05-02"
protocolSection.identificationModule.nctId: "NCT02109250"
protocolSection.identificationModule.officialTitle: "CAPRELSA\u00ae REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa\u00ae) in Current Clinical Practice"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.